HomeNewsIndiaGovt initiates consultation process for new science, technology and innovation policy

Govt initiates consultation process for new science, technology and innovation policy

The fifth S&T policy of the country is being formulated at a crucial juncture when India and the world are tackling the COVID-19 pandemic.

June 03, 2020 / 15:13 IST
Representative image

The government has initiated a consultation process for formulation of a new national Science, Technology and Innovation Policy (STIP 2020), a statement said.

The Office of the Principal Scientific Adviser to the Government of India (Office of PSA) and the Department of Science and Technology (DST) have jointly initiated a decentralised, bottom-up and inclusive process for the formulation of the new policy, it said.

The fifth S&T policy of the country is being formulated at a crucial juncture when India and the world are tackling the COVID-19 pandemic.

"As the crisis changes the world, the new policy with its decentralised manner of formation will reorient STI in terms of priorities, sectoral focus, the way research is done, and technologies are developed and deployed for larger socio-economic welfare," the statement issued on Tuesday said.

The formulation process for STIP 2020 is organised into four highly interlinked tracks, according to the statement.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Track I involves an extensive public and expert consultation process through Science Policy Forum - a dedicated platform for soliciting inputs from larger public and expert pool during and after the policy drafting process.

Track II comprises experts-driven thematic consultations to feed evidence-informed recommendations into the policy drafting process. Twenty-one focused thematic groups have been constituted for the purpose.

Track III involves consultations with ministries and states, while track IV constitutes apex level multi-stakeholder consultation.

For track III, nodal officers are being nominated in states and in ministries, departments and agencies of the Government of India for extensive intra-state and intra-department consultation.

For track IV, consultation with industry bodies, global partners and inter-ministerial and inter-state consultations represented at the highest levels are being carried out.

The consultation processes on different tracks have already started and are running in parallel.

The track-II thematic group (TG) consultation started with a series of information sessions last week.

During the information sessions, Akhilesh Gupta, the head of Policy Coordination and Programme Monitoring Division of DST, made the presentations and steered the discussions.

The sessions were attended by around 130 members of the 21 thematic groups along with 25 policy research fellows and scientists of DST and the Office of PSA.

"The STI policy for the new India will also integrate the lessons of COVID-19, including building of an 'atmanirbhar bharat' through ST&I (Science and Technology and Innovation) by leveraging our strengths in R&D, design, S&T workforce and institutions, huge markets, demographic dividend, diversity and data," said Ashutosh Sharma, Secretary, DST.

The six-month process involves broad-based consultations with all stakeholders within and beyond the scientific ecosystem of the country, including academia, industry, government, global partners, young scientists and technologists, civic bodies and the general public.

Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

PTI
first published: Jun 3, 2020 02:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347